ABATTIS BIOCEUTICALS ORD (ATTBF) earnings
Quarterly and annual ATTBF reports and results, each read against the price at its own news timestamp. Back to the ATTBF overview →
No ATTBF earnings events in the measured window.
Nothing matched in the current window — the ATTBF overview has every event we measure for this name.
Get an email when ATTBF moves on news →Keep exploring
More ATTBF: analyst actions → · SEC filings → · ATTBF overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Molecular Templates, Inc. (MTEM) | 84 | -0.48% | 39% |
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
| Intercept Pharmaceuticals, Inc. (ICPT) | 83 | +0.09% | 68% |
| Ethos Technologies Inc. - Class A (LIFE) | 83 | -0.31% | 32% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.